Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Global government bond yields stayed close to long-run peaks as energy market tensions and a string of hawkish central bank signals kept borrowing costs elevated. U.S. Treasuries held near multi-year highs after a crude oil surge linked to geopolitical developments, while Australian 10-year yields retreated following a Reserve Bank of Australia rat…
Brady (BRC) has turned a conservative, low-leverage profile into an opportunistic growth platform with the $1.4 billion acquisition of Honeywell's Productivity Solutions and Services. With no meaningful debt, recent organic strength, and an accretive deal that the market is still digesting, the stock offers a defined asymmetric trade: buy at $84 wi…
BIO-key International, a US-based biometric identity and access management provider, announced a strategic partnership with Dubai-based Al Majlis Group to bring advanced identity security solutions to government and private sector organizations in the UAE and Saudi Arabia. The collaboration leverages Al Majlis Group's regional expertise and BIO-key…
IDT (IDT) is showing clear traction in higher‑margin businesses — Fintech (BOSS Money), Net2phone cloud comms and NRS retail payments — which is lifting consolidated gross profit and operating income. At a market cap near $1.73B, trailing P/E ~21 and positive free cash flow, the stock looks set to reprice higher if growth continues. This is a mid‑t…
IBM reported a choppy quarter that knocked the stock lower, but fundamentals look intact: $13.79B in free cash flow, EPS of $11.38, and a market cap near $208B support a mid-term long with a clear entry, stop and target. This trade targets a rebound as AI and quantum initiatives reaccelerate consulting demand.
Pfizer combines a market-leading dividend (near 6%), strong free cash flow (roughly $11B trailing), and an evolving specialty and AI-enabled R&D footprint. Valuation metrics (EV/EBITDA ~9.6, P/S ~2.57) are reasonable for a large-cap pharma navigating LOE headwinds. We recommend a long trade to capture recovery as growth assets re-accelerate and cos…
Astera Labs is the leading pure-play provider of purpose-built connectivity silicon for rack-scale AI infrastructure. With record top-line momentum, Q3 guide of $540-560M (~40% sequential growth), and strong profitability metrics, the stock merits a tactical long with a plan to manage valuation risk. Key risks include competition, valuation, and a …
Imperial Oil (IMO) has rallied year-to-date but shows clear technical and fundamental vulnerabilities: falling moving averages, sub-50 RSI, meaningful short interest, and a valuation that still prices in steady commodity outcomes. This trade idea recommends a mid-term short into a continuation of the downtrend with defined entry, stop and target.
Analog Devices (ADI) looks set to sustain double-digit top-line growth through 2027 driven by industrial recovery, data-center AI spending, and RF SoC demand. Financials show strong free cash flow ($4.94B) and conservative leverage (debt/equity 0.27), while technicals support a bullish entry around $395.68. Trade plan: enter at $395.68, target $520…
Pharming Group N.V. announced the immediate departure of CEO Fabrice Chouraqui due to strategic differences with the Board. Interim co-CEOs Leverne Marsh and Kenneth Lynard have been appointed to ensure leadership continuity while a permanent successor is sought. The company reaffirmed its commitment to its strategic priorities and patient-focused …
Applied Optoelectronics is converting blistering demand for 800G and 1.6T optical transceivers into a manufacturing-led growth story. Near-term pain from capacity constraints and equity raises has weighed on the shares. We view the recent pullback as an actionable long with specific entry, stop and target tied to the company's capacity ramp and rev…
EHang Holdings Limited (Nasdaq: EH), a leader in Advanced Air Mobility technology, announced the expansion of its Global Fast Track Program to Vietnam, marking Hanoi as its first city-level partner. The company signed a Memorandum of Understanding with Hanoi's Department of Science and Technology and local partner HungViet Technology to conduct low…
Li Auto (LI) is trading near its 52-week low at $11.73 with a market cap of roughly $12.8B. Recent quarterly weakness and a product refresh compressed margins and turned profits negative, but the company still carries material cash, meaningful scale, and a valuation that looks attractive if execution stabilizes. This trade idea favors a disciplined…
Canadian Natural (CNQ) trades below its 20-day SMA amid geopolitical noise over the Strait of Hormuz. The company generates large operating cash flow, covers its dividend with room to spare, and sits at a valuation that already prices in commodity volatility. A mid-term long against $47.50 with a $43 stop and $52 target offers an asymmetric risk-re…
Lundin Gold looks reasonably priced relative to its producing asset and near-term catalysts. We like a structured long with a clear entry, stop and target while watching resource conversion and unit-cost trends. The trade is a medium-to-long-term directional idea that banks on operational improvements and upside from exploration and reserve convers…
MoneyHero Group's SingSaver, a leading Singapore personal finance platform, has launched a new home loans segment in partnership with Redbrick Mortgage Advisory to provide bank-by-bank rate comparisons and advisory services. This move expands SingSaver's offerings into Singapore's largest household debt category, addressing a growing refinancing tr…
Ichor Holdings designs and builds fluid delivery subsystems for semiconductor capital equipment. Recent results show accelerating revenue and margin expansion, management is guiding higher, and the stock has pulled back from its summer peak. For traders willing to accept semiconductor cycle risk and short-term volatility, Ichor offers an asymmetric…
The U.S. dollar remained near a two-month high as markets digested softer oil, a partial easing in Treasury bond selling and comments from a Fed policymaker that tempered expectations of imminent rate hikes. The Australian dollar slipped to multi-week lows despite an RBA rate increase, while the pound hovered close to its weakest level since late J…
NewGenIvf Group Limited (NASDAQ: NIVF) announced the pricing of a $1.25 million public offering consisting of 17.86 million ordinary shares and pre-funded warrants at $0.07 per share. Proceeds will be used for investing in AI ventures, restructuring debt, expanding manufacturing in cell-sorting technology, and general corporate needs. The offering …
TC Energy (TRP) yields ~4.25%, is trading near $58.70 and shows technical oversold readings. A recent $560M pipeline sale frees capital to redeploy into North America - we view that as a potential funding source for power-generation projects tied to data center demand. Trade plan: enter $58.70, stop $54.00, target $65.00 over a mid-term (45 trading…
Alphabet is a buy here. The stock trades at a reasonable P/E with a fortress balance sheet and strong cash generation. Near-term catalysts - new data-center builds and an industry move to custom silicon - should accelerate Google Cloud's margin profile, creating a re-rate opportunity. Enter $342.80, stop $320.00, target $390.00 over a 45-trading-da…
Julong Holding Limited, a Nasdaq-listed provider of intelligent integrated solutions, has entered into a securities purchase agreement to issue 750,000 Class A ordinary shares and 2,250,000 pre-funded warrants, generating gross proceeds of approximately $897,750. The funds raised will be used for general corporate purposes. The private placement is…
Quantum-Si released interim data demonstrating that its next-generation Proteus™ platform significantly outperforms its current Platinum® Pro instrument in protein sequencing scale, accuracy, and peptide identification. Despite still being in development, Proteus showed up to 30 times more alignments per chamber, markedly lower false discovery rate…
HUTCHMED, in collaboration with AstraZeneca, has submitted a New Drug Application to the US FDA for the combination of ORPATHYS (savolitinib) and TAGRISSO (osimertinib) for advanced non-small cell lung cancer (NSCLC) patients with MET overexpression or amplification after progression on EGFR-TKI therapy. The NDA is supported by the global SAFFRON P…
Meta is moving from a pure ad-platform story to a multi-revenue model built around personal AI agents, integrated hardware, and enterprise software. Recent product launches (Muse and new AI/AR glasses), executive hires, and strong cash generation give the company optionality to monetize services beyond ads. The stock is tradeable on pullbacks with …
